Burlington , Vermont , U.S.A. – February 4, 2005 – Triosyn Corp., a world leader in antimicrobial technology, has secured $2.0 million in venture financing from MMV Financial Inc.
Triosyn Corp. is a developer of products aimed at protecting against microbial threats. Its core technology, Triosyn® Resin, is the basis for its diverse product lines which include air masks, air filters, clothing and wound dressings. These protect against a wide range of bio-chemical threats, including anthrax, SARS, ebola and influenza. The company sells to both the military and commercial markets and has won major contracts with the U.S. Air Force and U.S. government in recent months for products assisting in defense and homeland security.
“Triosyn has developed a powerful antimicrobial technology that enables it to access many large markets, ranging from air filtration for the military and commercial markets to the life sciences sector,” said Ron Patterson, EVP, MMV Financial. “We believe the company has the opportunity to grow tremendously in the next three to five years.”
"This financing will allow Triosyn to further invest in the commercialization of our antimicrobial air filtration products while expanding our product portfolio with development in new applications,” said Pierre Jean Messier, CEO of Triosyn. “We are delighted to have attracted another investor of the caliber of MMV Financial.”
Triosyn Corp. has developed a unique antimicrobial technology for use in products designed to fight against microbial threats. In extensive third-party laboratory testing, the company’s core technology, Triosyn® resin, is proven effective against a broad spectrum of microorganisms. Triosyn® resin is versatile and equally effective in fluid, air, surface and dermatological applications. The company has developed a diversified portfolio of products in several areas, including air filtration (such as facemasks), paints and coatings, dermatological treatments, barrier textiles, protective clothing, and the purification of fluids. Triosyn Corp. is based near Burlington, Vermont, USA with research and development laboratories outside of Montreal, Quebec, Canada. For further information please visit http://www.triosyn.com/.
About MMV Financial
MMV Financial is a specialty finance company providing creative debt solutions directly to mid-stage technology and life sciences companies, with a focus on the Canadian and North American sectors. Previously known as MM Venture Partners, the firm is backed by top U.S. and Canadian private equity firms and financial institutions including Conning Capital Partners of Hartford, Connecticut, Caisse de dépôt et placement du Québec of Montreal, and Wells Fargo Foothill, a part of Wells Fargo Company. For more information visit http://www.mmvf.com/
# # #
For more information or to arrange for an interview, contact:
Executive Vice President
MMV Financial Inc.
Tel: (416) 977-9718
Fax: (416) 591-1393